I 
118TH CONGRESS 
1ST SESSION H. R. 2631 
To prohibit the Federal Government from imposing any mandate requiring 
an individual to receive a vaccine that has not been authorized for 
marketing for at least 10 years, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 17, 2023 
Mr. SANTOS introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To prohibit the Federal Government from imposing any man-
date requiring an individual to receive a vaccine that 
has not been authorized for marketing for at least 10 
years, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Medical Information 
Nuanced Accountability Judgement Act of 2023’’ or the 
‘‘MINAJ Act of 2023’’. 
VerDate Sep 11 2014 
22:40 Apr 18, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2631.IH
H2631
pbinns on DSKJLVW7X2PROD with $$_JOB
SEC. 2. PROHIBITION AGAINST VACCINE MANDATES PRIOR 
TO MARKETING APPROVAL FOR AT LEAST 10 
YEARS. 
(a) PROHIBITION.—The Federal Government shall 
not establish, implement, or enforce any mandate requir-
ing an individual to receive a vaccine that has not been 
authorized for marketing for at least 10 years. 
(b) PUBLIC HEALTH EMERGENCY EXCEPTION.— 
Subsection (a) does not apply if— 
(1) the mandate is intended to prevent or miti-
gate a disease with respect to which a public health 
emergency declaration is in effect; and 
(2) the Federal department or agency seeking 
to impose the mandate— 
(A) submits a report to the appropriate 
committees of Congress— 
(i) giving notice of the intent to im-
pose the mandate; and 
(ii) including all data in the posses-
sion of the department or agency on the 
safety and efficacy of the vaccine involved; 
and 
(B) gives the appropriate committees of 
Congress a sufficient period to conduct exten-
sive review of the matters in such report. 
VerDate Sep 11 2014 
22:40 Apr 18, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2631.IH
H2631
pbinns on DSKJLVW7X2PROD with $$_JOB
(c) SUFFICIENT PERIOD OF TIME.—For purposes of 
subsection (b)(2)(B), a sufficient period shall be the lesser 
of— 
(1) 3 months; and 
(2) the period over which the appropriate com-
mittees of Congress each complete three hearings on 
the matters in the report submitted under subsection 
(b)(2)(A). 
(d) DEFINITIONS.—In this section: 
(1) The term ‘‘appropriate committees of Con-
gress’’ means— 
(A) the Committee on Energy and Com-
merce of the House of Representatives; and 
(B) the Committee on Health, Education, 
Labor, and Pensions of the Senate. 
(2) The term ‘‘authorized for marketing’’ 
means licensed, approved, or authorized under— 
(A) section 351 of the Public Health Serv-
ice Act (42 U.S.C. 262); or 
(B) section 505 or 564 of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 355, 
360bbb–3). 
(3) The term ‘‘mandate’’ includes any condition 
imposed on— 
(A) hiring or employment; or 
VerDate Sep 11 2014 
22:40 Apr 18, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H2631.IH
H2631
pbinns on DSKJLVW7X2PROD with $$_JOB
(B) the receipt of a service or benefit. 
(4) The term ‘‘public health emergency declara-
tion’’ means a public health emergency declaration 
under section 319 of the Public Health Service Act 
(42 U.S.C. 247d). 
Æ 
VerDate Sep 11 2014 
22:40 Apr 18, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H2631.IH
H2631
pbinns on DSKJLVW7X2PROD with $$_JOB